Interview with Manfred Paul, Director, Naari AG Russia/CIS
Since our last report on Russia in 2007, there has been much emphasis placed on developing local industry, and reducing the nation’s reliance on imported pharmaceutical products. How do you…
Address:
Tel: +41 615880242
Web: http://www.naari.ch/
NAARI aspires to be a world leader in the area of female healthcare, providing medical solutions from puberty to menopause. Our aim is to be the world’s first 100% integrated generic female health pharmaceutical company. This implies complete involvement in every step of production, going from plant extract to final dosage forms. By giving our stake holders cutting edge expertise, we set the standard for female health products, globally.
NAARI’s core expertise lies in manufacturing Active Pharmaceutical Ingredients (APIs) and Formulations focusing exclusively on the female health segment with a special emphasis on high active female hormones.
The nature of our work and our dedication to fulfilling our vision demands a deeply ingrained set of values that are integral to our processes and operations. Here, we affirm those values by providing high quality, affordable and innovative solutions.
APIs, Formulations, Intermediates, Diagnostics
Since our last report on Russia in 2007, there has been much emphasis placed on developing local industry, and reducing the nation’s reliance on imported pharmaceutical products. How do you…
Last time Focus Reports met with you in 2006, the Russian pharmaceutical industry had enjoyed five straight years of growth. This growth has since continued through 2011. Can you provide…
There is a long history of trade between Russia and Britain. The Chamber of Commerce started in 1916. Can you outline how the organisation has evolved and its current role…
When the Russian Federation emerged from the former USSR in 1991 all the structures of the past social net that provided for the complete healthcare needs of citizens were…
See our Cookie Privacy Policy Here
